heart failure glp-1 Mechanisms of Receptor Agonists in HFpEF: Exploring Weight-Dependent and Independent Drivers of Therapeutic Benefit Cardiovascular disease continuum-GLP-1 action. Adapted
Description
Limitations Article heterogenicity There are several limitations of this review, most of which are due to the nature of the articles included
doi: 10.1016/j.clnu.2021.11.014
The RNAi clones were obtained from RNAi feeding libraries created by Julie Ahringer and Marc Vidals laboratories 75,76
Contributed by Rachel, Tannan Plastic Surgery Nurse
While this percentage might seem small, it is significant enough to warrant attention
